Bill Powers: Pickens and Stansberry Wrong, Shale Gas Production to Fall
Source: Tom Armistead of The Energy Report  (5/7/13)
Energy pundits sing natural gas' praises, but Bill Powers, author of "Cold, Hungry and in the Dark: Exploding the Natural Gas Supply Myth," isn't buying it. He sees serious flaws in how reserves are reported, and his own research shows steep, across-the-board production declines in the near future. Nonetheless, he expects a multiyear bull run for the resource, and recommends investors get positioned before scarcity hits—just five to seven years from now. Find out which companies Powers is betting on in this interview with The Energy Report. More >

Case in Point: How Following this 5-Step Biotech Investing Strategy Can Double Your Money
Source: Michael Robinson, Strategic Tech Investor  (5/7/13)
"This strategy can avoid some of the biotech sector's biggest risks, while giving you access to the high growth and high returns. And it still gives us the chance to find double-your-money stocks—the chief objective of the Five Tech-Wealth-Investing Rules." More >

Porter Stansberry vs. Marin Katusa: I Win, You Lose!
Source: Marin Katusa, Casey Research  (5/7/13)
"This means there are tremendous opportunities to profit while we wait for the rest of the world to catch up." More >

Special Report from the SME Conference: How to Find Money in Any Market
Source: JT Long of The Gold Report  (5/6/13)
Money: Mining companies need it and investors want to know that companies will use that money to make them money. An innovative conference sponsored by the Society for Mining, Metallurgy and Exploration (SME), called "Current Trends in Mining Finance—An Executive's Guide: What Are Lenders, Investors Looking For?", brought together about 145 experts who were actively funding and running companies—and looking for answers. In this interview with The Gold Report,
SME Executive Director David Kanagy and Conference Co-Chair Tim Alch share some insights about alternative funding that could help more companies survive the year.
More >

Are Palladium Stockpiles Running Out?
Source: Sholom Sanik, Resource Investor  (5/6/13)
"The market is absorbing a supply-side shock from two fronts." More >

How to Make Money in Range-Bound Energy Markets
Source: Kent Moors, Oil & Energy Investor  (5/6/13)
"Hedge using market sectors." More >

Ryan Walker: Tweet Retreat Hasn't Changed Gold's Story
Source: Brian Sylvester of The Gold Report  (5/3/13)
Investors were shaken by the market's death-defying drop and recovery in a matter of minutes recently. But the "tweet retreat" hasn't changed the reasons why investors need gold companies in their portfolio. Ryan Walker, a mining analyst with Casimir Capital in Toronto, tells investors to look past the headlines to what underpins the market. In this interview with The Gold Report, Walker says all the cash pumped into the economy has to start driving inflation at some point. More >

James Dines Follows His Prediction of a Commodity Crash with Another One the Mainstream Media Is Ignoring
Source: JT Long of The Gold Report  (5/3/13)
When the metals markets tumbled in mid-April, The Gold Report reached out to "the original investor bug" and author of The Dines Letter, James Dines, for perspective. He predicted a crash in commodity prices two years ago based on his analysis of a weak Chinese economy. Next, he says, will be a bond market bust once interest rates start to climb. This will lead to "a stampede to get out of bonds like a herd of elephants attempting to exit through a revolving door." How can investors protect themselves? That is Dinesism #38. More >

Physical Gold-Silver Shortage Could Benefit Undervalued Miners
Source: Jeb Handwerger, Gold Stock Trades  (5/3/13)
"We may see a very powerful rebound as short covering and record investment demand returns to the precious metal sector." More >

Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Source: George S. Mack of The Life Sciences Report  (5/2/13)
In January 2013, The Life Sciences Report debuted its biotech Watchlist, which outlined ideas for investors keyed to catalysts in the drug development process that typically move biotechnology stocks. All stocks are affected by catalysts, but nowhere do they provide more leverage (or deleverage) than in biotech. We predicted the new year would present legitimate prospects for portfolio growth. So far, that has been the case. Although the party has given way to some fatigue, the punch bowl is still on the table and the biotech upswing continues. More >

James McIlree: Three Companies Could Transform Power Production
Source: Peter Byrne of The Energy Report  (5/2/13)
Energy tech companies have a business model that's closer to Apple Inc. than Apache Corp. In other words, it's all about the new product. The products Dominick & Dominick Analyst James McIlree is excited about offer major benefits like improved geological mapping for oil and gas explorers, or electric grid safety for energy utilities. In an interview with The Energy Report, McIlree talks about his favorite companies in the energy tech space and how understanding product cycles can help investors time their buys. More >

Silver Prices in 2013: The Reasons for a Bold Forecast
Source: Diane Alter, Money Morning   (5/2/13)
"Investing now in beaten down silver could prove very rewarding." More >

How to Stress Test Gold Equities: Joe Mazumdar
Source: Peter Byrne of The Gold Report  (5/1/13)
Gold prices are down in the short term, but the commodity metal is here to stay, says geologist Joe Mazumdar. In this interview with The Gold Report,
the Canaccord Genuity analyst assesses the current situation and compares the performance potential of the majors with the mid caps. He backs up his analysis and predictions with a few solid companies that are positioned to weather the storm.
More >

Gold Stocks to Rebound in May
Source: Jordan Roy-Byrne, The Daily Gold  (5/1/13)
"Sell in May and don't go away. Sell and buy gold stocks." More >

The Approval Process in Action
Source: The Life Sciences Report and Visual Capitalist  (5/1/13)
What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts. More >

The Approval Process in Action
Source: The Life Sciences Report and Visual Capitalist  (5/1/13)
What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts. More >

The Approval Process in Action
Source: The Life Sciences Report and Visual Capitalist  (5/1/13)
What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts. More >

Luisa Moreno: Brace Yourself for Three More Years of Heavy Rare Earth Shortages
Source: Brian Sylvester of The Metals Report  (4/30/13)
Rare earth elements are a crucial component of our everyday lives, but many of the companies unearthing them are still learning to navigate the supply chain. Those that can master the dance of metallurgy and end-user relationships will find success, says Luisa Moreno, a senior research analyst with Euro Pacific in Toronto. In this interview with The Metals Report, Moreno updates us on which miners are making the most progress. More >

Bob Moriarty: US Energy Self-Sufficiency Nothing But 'Feel-Good BS'
Source: JT Long of The Energy Report  (4/30/13)
What the "tree huggers" don't realize, says 321energy.com founder Bob Moriarty, is that "the BMWs they drive to anti-Keystone protests need fuel." But the pipeline supporters who expect that fuel to come from American sources are just as delusional, Moriarty asserts in his scathing interview with The Energy Report. That's why he's looking beyond North America for lucrative oil plays. Find out which international producers may be ideally positioned to supply an energy-hungry U.S., and why Moriarty believes oil should be taxed "to the limit." More >

China's Secret Energy Investments
Source: Economy Watch  (4/30/13)
"There have been 1,673 undocumented Chinese development projects in 50 African countries over the past decade." More >

Gold's Plunge Ultimately Healthy for the Sector: Michael Gray
Source: Brian Sylvester of The Gold Report  (4/29/13)
Market volatility sets the stage for price upswings as well as dips, according to Michael Gray, equities analyst of Macquarie Capital Markets, and the recent gold price drop should be seen as a "pause" in the bull market. Management teams are pausing as well, to focus on earnings and shareholder return rather than growth. In this interview with The Gold Report, Gray says this is the time to buy the best companies you can while they are discounted to fire sale prices, and he offers several names in jurisdictions from South and North America in the junior explorer space. More >

Breaking Down Gold's Comeback
Source: Greg Guenthner, The Daily Reckoning  (4/29/13)
"It's only been two weeks since the big crash. But that hasn't stopped the yellow metal from staging a comeback. For the first time in five weeks, gold ended trading Friday night with a weekly gain under its belt." More >

New Wyoming Lithium Deposit Could Meet All U.S. Demand
Source: John Daly, OilPrice.com   (4/29/13)
"Last year virtually all of the major brine and mineral-based lithium producers increased their prices, which in turn has spurred prospecting." More >

Sell in May and Miss a Chance to Buy Gold Stocks Cheap, Warns Bob Moriarty
Source: JT Long of The Gold Report  (4/26/13)
What is up—the Dow Jones Industrial Average and Standard & Poor's 500—will come down and what is down—gold equities—will go up fast, predicts the ultimate contrarian investor, Bob Moriarty. In this interview with The Gold Report, the president of 321 Gold proclaims that while all gold stocks are cheap right now, he has some favorites that he expects to jump when the junior market turns. Those who turn their back on the market over the summer just might lose their best chance to get in at historic lows. More >

Biotech Micro Caps Offer Promise of Mighty Returns: Dick Huebner
Source: George S. Mack of The Life Sciences Report  (4/25/13)
Dick Huebner knows what he wants. He's looking for biotech companies that can make it very big from a near zero-base valuation. We're talking low-end micro caps that bring a lot of risk to the table, along with the opportunity for major gains. In this interview with The Life Sciences Report, GVC Capital's senior managing partner profiles three publicly traded life sciences stories that could produce generous windfalls for investors, and a private firm about to go public that promises to do the same. More >